eMedicine Specialties > Obstetrics and Gynecology > Obstetrical Complications

Evaluation of Fetal Death: Multimedia

Author: James L Lindsey, MD, Staff Physician, Santa Clara Valley Medical Center, Affiliated Clinical Associate Professor, Stanford School of Medicine, Department of Obstetrics and Gynecology, Santa Clara Valley Medical Center
Contributor Information and Disclosures

Updated: Dec 18, 2008

Multimedia

This is an example of a checklist to be used foll...
(Enlarge Image)
Media file 1: This is an example of a checklist to be used following fetal death. Courtesy of Santa Clara Valley Medical Center.
[ CLOSE WINDOW ]
This is an example of a checklist to be used foll...

This is an example of a checklist to be used following fetal death. Courtesy of Santa Clara Valley Medical Center.

More on Evaluation of Fetal Death

References
[ CLOSE WINDOW ]

References

  1. Dickinson JE, Evans SF. A comparison of oral misoprostol with vaginal misoprostol administration in second-trimester pregnancy termination for fetal abnormality. Obstet Gynecol. Jun 2003;101(6):1294-9. [Medline].

  2. ACOG Committee Opinion No. 383: Evaluation of stillbirths and neonatal deaths. Obstet Gynecol. Oct 2007;110(4):963-6. [Medline].

  3. American College of Obstetricians and Gynecologists. ACOG Committee opinion. Perinatal and infant mortality statistics. Number 167, December 1995. Committee on Obstetric Practice. American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet. Apr 1996;53(1):86-8. [Medline].

  4. American College of Obstetricians and Gynecologists. ACOG practice bulletin. Management of recurrent pregnancy loss. Number 24, February 2001. (Replaces Technical Bulletin Number 212, September 1995). American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet. Aug 2002;78(2):179-90. [Medline].

  5. American College of Obstetricians and Gynecologists. Diagnosis and management of fetal death. ACOG Technical Bulletin Number 176-January 1993. Int J Gynaecol Obstet. Sep 1993;42(3):291-9. [Medline].

  6. Arkel YS, Ku DH. Thrombophilia and pregnancy: review of the literature and some original data. Clin Appl Thromb Hemost. Oct 2001;7(4):259-68. [Medline].

  7. Barfield WD, Tomashek KM, Flowers LM, et al. Contribution of late fetal deaths to US perinatal mortality rates, 1995-1998. Semin Perinatol. Feb 2002;26(1):17-24. [Medline].

  8. Chamley LW. Antiphospholipid antibodies: biological basis and prospects for treatment. J Reprod Immunol. Oct-Nov 2002;57(1-2):185-202. [Medline].

  9. Copper RL, Goldenberg RL, DuBard MB, et al. Risk factors for fetal death in white, black, and Hispanic women. Collaborative Group on Preterm Birth Prevention. Obstet Gynecol. Oct 1994;84(4):490-5. [Medline].

  10. de la Vega A, Verdiales M. Failure of intensive fetal monitoring and ultrasound in reducing the stillbirth rate. P R Health Sci J. Jun 2002;21(2):123-5. [Medline].

  11. French AE, Gregg VH, Newberry Y, et al. Umbilical cord stricture: a cause of recurrent fetal death. Obstet Gynecol. May 2005;105(5 Pt 2):1235-9. [Medline].

  12. [Best Evidence] Fretts RC. Etiology and prevention of stillbirth. Am J Obstet Gynecol. Dec 2005;193(6):1923-35. [Medline].

  13. Fretts RC, Boyd ME, Usher RH, et al. The changing pattern of fetal death, 1961-1988. Obstet Gynecol. Jan 1992;79(1):35-9. [Medline].

  14. Frias AE Jr, Luikenaar RA, Sullivan AE, et al. Poor obstetric outcome in subsequent pregnancies in women with prior fetal death. Obstet Gynecol. Sep 2004;104(3):521-6. [Medline].

  15. Froen JF, Gardosi JO, Thurmann A, et al. Restricted fetal growth in sudden intrauterine unexplained death. Acta Obstet Gynecol Scand. Sep 2004;83(9):801-7. [Medline].

  16. Gaudino JA Jr. Fetal Deaths. From data to action; CDC's Public Health Surveillance for Women, Infants, and Children. CDC's Maternal & Child Health Monograph. 1994.;Atlanta, Ga.

  17. Geis W, Branch DW. Obstetric implications of antiphospholipid antibodies: pregnancy loss and other complications. Clin Obstet Gynecol. Mar 2001;44(1):2-10. [Medline].

  18. Gonen R, Lavi N, Attias D, et al. Absence of association of inherited thrombophilia with unexplained third-trimester intrauterine fetal death. Am J Obstet Gynecol. Mar 2005;192(3):742-6. [Medline].

  19. Gross SJ, Phillips OP, Shulman LP, et al. Adverse perinatal outcome in patients screen-positive for neural tube defects and fetal Down syndrome. Prenat Diagn. Jul 1994;14(7):609-13. [Medline].

  20. Heller DS, Rush D, Baergen RN. Subchorionic hematoma associated with thrombophilia: report of three cases. Pediatr Dev Pathol. May-Jun 2003;6(3):261-4. [Medline].

  21. Hurtado V, Montes R, Gris JC, et al. Autoantibodies against EPCR are found in antiphospholipid syndrome and are a risk factor for fetal death. Blood. Sep 1 2004;104(5):1369-74. [Medline].

  22. Hyde LK, Cook LJ, Olson LM, et al. Effect of motor vehicle crashes on adverse fetal outcomes. Obstet Gynecol. Aug 2003;102(2):279-86. [Medline].

  23. Incerpi MH, Miller DA, Samadi R, et al. Stillbirth evaluation: what tests are needed?. Am J Obstet Gynecol. Jun 1998;178(6):1121-5. [Medline].

  24. Kochanek KD, Smith BL. Deaths: preliminary data for 2002. Natl Vital Stat Rep. Feb 11 2004;52(13):1-47. [Medline].

  25. Lockwood CJ. Heritable coagulopathies in pregnancy. Obstet Gynecol Surv. Dec 1999;54(12):754-65. [Medline].

  26. Many A, Elad R, Yaron Y, et al. Third-trimester unexplained intrauterine fetal death is associated with inherited thrombophilia. Obstet Gynecol. May 2002;99(5 Pt 1):684-7. [Medline].

  27. [Best Evidence] Nohr EA, Bech BH, Davies MJ, et al. Prepregnancy obesity and fetal death: a study within the Danish National Birth Cohort. Obstet Gynecol. Aug 2005;106(2):250-9. [Medline].

  28. Nybo Andersen AM, Hansen KD, Andersen PK, et al. Advanced paternal age and risk of fetal death: a cohort study. Am J Epidemiol. Dec 15 2004;160(12):1214-22.

  29. Nyman M, Skjoldebrand-Sparre L, Broliden K. Non-hydropic intrauterine fetal death more than 5 months after primary parvovirus B19 infection. J Perinat Med. 2005;33(2):176-8. [Medline].

  30. Ogunyemi D, Ku W, Arkel Y. The association between inherited thrombophilia, antiphospholipid antibodies and lipoprotein A levels with obstetrical complications in pregnancy. J Thromb Thrombolysis. Oct 2002;14(2):157-62. [Medline].

  31. Pauli RM, Reiser CA. Wisconsin Stillbirth Service Program: II. Analysis of diagnoses and diagnostic categories in the first 1,000 referrals. Am J Med Genet. Apr 1 1994;50(2):135-53. [Medline].

  32. Radestad I, Steineck G, Nordin C, et al. Psychological complications after stillbirth--influence of memories and immediate management: population based study. BMJ. Jun 15 1996;312(7045):1505-8. [Medline].

  33. Rey E, Kahn SR, David M, et al. Thrombophilic disorders and fetal loss: a meta-analysis. Lancet. Mar 15 2003;361(9361):901-8. [Medline].

  34. Salihu HM, Kinniburgh BA, Aliyu MH, et al. Racial disparity in stillbirth among singleton, twin, and triplet gestations in the United States. Obstet Gynecol. Oct 2004;104(4):734-40. [Medline].

  35. Silver RM. Fetal death. Obstet Gynecol. Jan 2007;109(1):153-67. [Medline].

  36. Silver RM, Varner MW, Reddy U, et al. Work-up of stillbirth: a review of the evidence. Am J Obstet Gynecol. May 2007;196(5):433-44. [Medline].

  37. Smulian JC, Ananth CV, Vintzileos AM, et al. Fetal deaths in the United States. Influence of high-risk conditions and implications for management. Obstet Gynecol. Dec 2002;100(6):1183-9. [Medline].

  38. US Deparment of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics. Vital and Health Statistics. Perinatal Mortality in the United States. Atlanta, Ga: 1985-91. [Full Text].

  39. US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics. State Definitions and Reporting Requirements for Live Births, Fetal Deaths, and Induced Terminations of Pregnancy. Atlanta, Ga: Centers for Disease Control and Prevention; 1997. Revision. 1997;[Full Text].

  40. US Department of Health and Human Servies, Centers for Disease Control and Prevention, National Center for Health Statistics. Procedures for coding cause of fetal death under ICD-10. 2005.

  41. US Department of Health and Human Servies, Centers for Disease Control and Prevention, National Center for Health Statistics: Vital and Health Statistics. Perinatal mortality in the United States: Preliminary data for 2003. 2005;53:15.

  42. Vintzileos AM, Ananth CV, Smulian JC, et al. Prenatal care and black-white fetal death disparity in the United States: heterogeneity by high-risk conditions. Obstet Gynecol. Mar 2002;99(3):483-9. [Medline].

  43. Weiss HB, Songer TJ, Fabio A. Fetal deaths related to maternal injury. JAMA. Oct 17 2001;286(15):1863-8. [Medline].

[ CLOSE WINDOW ]

Further Reading

[ CLOSE WINDOW ]

Keywords

evaluation of fetal death, stillbirth, fetal demise, perinatal death, pregnancy loss after 20 weeks' gestation, fetal heart tones, fetal movement, fetal surveillance, induction, oxytocin, preinduction cervical ripening, antiphospholipid syndrome, cord occlusion, abruptio placentae, pregnancy loss, fetal death, fetal death evaluation, fetal demise evaluation, evaluation of fetal demise

[ CLOSE WINDOW ]

Contributor Information and Disclosures

Author

James L Lindsey, MD, Staff Physician, Santa Clara Valley Medical Center, Affiliated Clinical Associate Professor, Stanford School of Medicine, Department of Obstetrics and Gynecology, Santa Clara Valley Medical Center
James L Lindsey, MD is a member of the following medical societies: American College of Obstetricians and Gynecologists, American Institute of Ultrasound in Medicine, American Society for Colposcopy and Cervical Pathology, and California Medical Association
Disclosure: Nothing to disclose.

Medical Editor

Andrea Witlin, DO, PhD, Former Assistant Professor, Department of Obstetrics and Gynecology, University of Texas Medical Branch
Andrea Witlin, DO, PhD is a member of the following medical societies: Society for Maternal-Fetal Medicine
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.

CME Editor

Frederick B Gaupp, MD, Consulting Staff, Department of Family Practice, Hancock Medical Center
Frederick B Gaupp, MD is a member of the following medical societies: American Academy of Family Physicians
Disclosure: Nothing to disclose.

Chief Editor

Carl V Smith, MD, The Distinguished Chris J and Marie A Olson Chair of Obstetrics and Gynecology, Professor, Department of Obstetrics and Gynecology, University of Nebraska Medical Center
Carl V Smith, MD is a member of the following medical societies: American College of Obstetricians and Gynecologists, American Institute of Ultrasound in Medicine, American Medical Association, Arkansas Medical Society, Association of Professors of Gynecology and Obstetrics, Central Association of Obstetricians and Gynecologists, Council of University Chairs of Obstetrics and Gynecology, Nebraska Medical Association, and Society for Maternal-Fetal Medicine
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.